Qiagen N.V. SEC filings QGEN

Qiagen N.V. has 512 filings in SEC EDGAR's recent list, going back to Oct 6, 1998. Its latest annual report, Form 20-F, was filed on Mar 20, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Nov 6, 2026. The company's fiscal year ends on December 31.

Form Description Filed Period
S-8 Employee stock plan registration May 30, 2024 —
S-8 Employee stock plan registration May 5, 2017 —
S-8 Employee stock plan registration Apr 2, 2015 —
S-8 Employee stock plan registration Nov 17, 2011 —
424B5 Prospectus supplement Sep 25, 2009 —
424B5 Prospectus supplement Sep 23, 2009 —
F-3ASR Form f-3 Sep 22, 2009 —
424B3 Prospectus Aug 7, 2007 —
S-8 Employee stock plan registration Aug 7, 2007 —
424B3 Prospectus Jul 25, 2007 —
F-4/A Amendment no. 2 to form f-4 Jul 18, 2007 —
F-4/A Amendment no. 1 to form f-4 Jul 5, 2007 —
F-4 Form f-4 Jun 15, 2007 —
424B3 Prospectus Jun 6, 2007 —
F-4/A Amendment no. 1 to form f-4 May 31, 2007 —
F-4 Form f-4 May 11, 2007 —
S-8 Employee stock plan registration Aug 10, 2005 —
S-8 Employee stock plan registration Jul 30, 2003 —
POS AM Post-effective amendment no. 1 to form f-3 Apr 4, 2003 —
F-3 Shelf registration (foreign issuer) Jun 28, 2002 —

Showing 20 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
QGEN (NYSE)
Fiscal year ends
December 31
Incorporated in
Netherlands
Headquarters
Pl Venlo
SEC filer status
Large accelerated filer
SEC CIK
1015820
Former names
QIAGEN NV (until Feb 14, 2020)

Other Biological Products, (No Diagnostic Substances) companies

All 182 Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.